BRIEF-Cumberland Pharmaceuticals Q2 adjusted loss per share $0.05
August 08, 2017 at 16:16 PM EDT
* Cumberland Pharmaceutical reports double digit revenue growth for the fourth consecutive quarter
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.